S&P 500
(-0.68%) 5 081.38 points
Dow Jones
(-0.81%) 38 076 points
Nasdaq
(-0.82%) 15 852 points
Oil
(-1.10%) $81.72
Gas
(-0.79%) $2.01
Gold
(-2.12%) $2 307.60
Silver
(-3.56%) $26.68
Platinum
(-1.90%) $943.20
USD/EUR
(0.41%) $0.936
USD/NOK
(0.93%) $11.08
USD/GBP
(0.42%) $0.799
USD/RUB
(0.29%) $93.57

实时更新: PolyPeptide Group AG [PPGN.SW]

交易所: SIX 部门: Healthcare 工业: Drug Manufacturers—Specialty & Generic
最后更新时间30 Apr 2024 @ 23:31

-0.33% CHF 30.30

Live Chart Being Loaded With Signals

Commentary (30 Apr 2024 @ 23:31):

PolyPeptide Group AG operate as a contract development and manufacturing company worldwide. It focuses on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development, and in generic products...

Stats
今日成交量 21 479.00
平均成交量 63 835.00
市值 998.98M
EPS CHF0 ( 2024-03-12 )
Last Dividend CHF0 ( N/A )
Next Dividend CHF0 ( N/A )
P/E -19.80
ATR14 CHF0.0950 (0.31%)

音量 相关性

長: 0.11 (neutral)
短: -0.03 (neutral)
Signal:(69.22) Neutral

PolyPeptide Group AG 相关性

10 最正相关
10 最负相关

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

PolyPeptide Group AG 相关性 - 货币/商品

The country flag 0.71
( moderate )
The country flag 0.77
( moderate )
The country flag 0.09
( neutral )
The country flag 0.77
( moderate )
The country flag -0.62
( weak negative )
The country flag -0.32
( neutral )

PolyPeptide Group AG 财务报表

Annual 2023
营收: CHF320.37M
毛利润: CHF4.64M (1.45 %)
EPS: CHF-1.560
FY 2023
营收: CHF320.37M
毛利润: CHF4.64M (1.45 %)
EPS: CHF-1.560
FY 2022
营收: CHF280.98M
毛利润: CHF51.99M (18.50 %)
EPS: CHF0.240

Financial Reports:

No articles found.

PolyPeptide Group AG

PolyPeptide Group AG operate as a contract development and manufacturing company worldwide. It focuses on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development, and in generic products. It engages in manufacturing custom research grade peptides; and developing neoantigen peptide to support personalized cancer therapies. The company is also involved in manufacturing peptides for commercially approved peptide therapeutics. In addition, it manufactures peptide-based generics for human and veterinary markets; and cosmetic peptides. Further, the company offers regulatory affair support services. The company was founded in 1952 and is headquartered in Zug, Switzerland. PolyPeptide Group AG is a subsidiary of Draupnir Holding B.V.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。